Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 456
Immune Disorders Drugs 193
Cardiovascular Drugs 157
Drug Discovery 148
Infectious Diseases Drugs 132
Biopharmaceuticals 127
Endocrine and Metabolic Disorders Drugs 111
Clinical Trials 107
Central Nervous System Drugs 105
Musculoskeletal Disorders Drugs 96
Pharmaceuticals 95
Leukemia Drugs 80
Hematological Drugs 77
Liver and Kidney Disorders Drugs 75
Lymphoma Drugs 62
Diabetes Drugs 57
Dermatological Drugs 57
Skin Cancer Drugs 48
Brain Cancer Drugs 46
Respiratory Drugs 45
Mental Disorders Drugs 43
Lung Cancer Drugs 39
Gastrointestinal Drugs 38
Pharmaceutical Intermediates 34
Drug Delivery 34
Immunosuppressive Drugs 33
Pharmaceutical Manufacturing 31
Infusions and Injectables 30
Liver Cancer Drugs 29
Analgesics 27
Antibiotics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 21
Pancreatic Cancer Drugs 19
Prostate Cancer Drugs 18
Urological Disorders Drugs 18
Colon Cancer Drugs 17
HIV/AIDS Drugs 17
Schizophrenia Drugs 17
Cervical Cancer Drugs 16
Sexual and Reproductive Health Drugs 16
Ovarian Cancer Drugs 15
Thyroid Cancer Drugs 14
Breast Cancer Drugs 13
Cancer Vaccines 13
Psoriasis Drugs 12
Over the Counter (OTC) Drugs 11
Biosimilars and Biosuperiors 11
Generic Drugs 10
Anti-Obesity Drugs 9
Optical Disorders Drugs 8
Vaccines 8
Transdermal and Transmucosal Drug Delivery 7
Alzheimer's Disease Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Cough and Cold Drugs 5
Anxiety Drugs 4
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Asthma Drugs 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Allergy Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



278 reviews

2,403 Results (Page 54 of 121)
- Relevance
  Sort by

Psoriasis Market Report 2025

 Report
April 2025
175 Pages
Global

From

€3965EUR$4,490USD£3,436GBP

Pancreatic Cancer - Competitive Landscape, 2024

 Clinical Trials
December 2024
550 Pages
Global

From

€4415EUR$5,000USD£3,827GBP

Analyzing the Global Pharmaceutical Industry 2022

 Report
November 2022
500 Pages
Global

From

€1324EUR$1,500USD£1,148GBP

Metastatic Prostate Cancer- Pipeline Insight, 2025

 Clinical Trials
April 2025
180 Pages
Global

From

€2649EUR$3,000USD£2,296GBP

Genitourinary Drugs Market by Indication, Therapeutic Class, Distribution Channel, End User, Route Of Administration, Formulation, Sales Model - Global Forecast 2025-2030

 Report
August 2025
192 Pages
Global

From

€3130EUR$3,545USD£2,713GBP

€3478EUR$3,939USD£3,015GBP

NEED HELP FINDING THE RIGHT PRODUCT? Eman will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Precision and Personalized Medicine in Pharma - Thematic Intelligence

 Report
June 2023
62 Pages
Global

From

€1722EUR$1,950USD£1,492GBP

Acute Ischemic Stroke Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

 Report
November 2022
565 Pages
Global

From

€2207EUR$2,500USD£1,913GBP

Prostate Cancer Therapeutics Market

 Report
January 2024
200 Pages
Global

From

€3664EUR$4,150USD£3,176GBP

Branded Generics Market by Dosage Form (Injections, Liquids, Tablets & Capsules), Therapeutic Area (Anti-Infectives, Cardiovascular, Central Nervous System), Application, Distribution Channel - Global Forecast 2025-2030

 Report
August 2025
181 Pages
Global

From

€3130EUR$3,545USD£2,713GBP

€3478EUR$3,939USD£3,015GBP

Rheumatoid Arthritis Therapeutics Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

 Report
August 2022
96 Pages
Global

From

€3500EUR$4,246USD£3,140GBP

Microbiome Manufacturing Market (3rd Edition): Industry Trends and Global Forecasts, till 2035: Distribution by Type of Product Manufactured, Type of Formulation, Type of Primary Packaging Used, Scale of Operation, Company Size, Key Geographical Regions and Leading Developers

 Report
February 2024
286 Pages
Global

From

€4237EUR$4,799USD£3,673GBP

Bile Duct Cancer Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
June 2025
211 Pages
Global

From

€4410EUR$4,995USD£3,823GBP

Drugs for Benign Prostatic hypertrophy Market Report 2025

 Report
April 2025
175 Pages
Global

From

€3965EUR$4,490USD£3,436GBP

Prostate Cancer Drugs Market Report 2025

 Report
April 2025
175 Pages
Global

From

€3965EUR$4,490USD£3,436GBP

Antidepressants Drugs Market 2025-2029

 Report
June 2025
209 Pages
Global

From

€2207EUR$2,500USD£1,913GBP

Antidotes Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3965EUR$4,490USD£3,436GBP

Heart Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
35 Pages
Global

From

€1766EUR$2,000USD£1,531GBP

Prostate Cancer Therapeutics Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type, End User, and Geography

 Report
December 2023
150 Pages
Global

From

€3929EUR$4,450USD£3,406GBP

Gastroenteritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
July 2022
64 Pages
Global

From

€1766EUR$2,000USD£1,531GBP

Eosinophilic Esophagitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
July 2022
86 Pages
Global

From

€1766EUR$2,000USD£1,531GBP

2,403 Results (Page 54 of 121)
- 1
- 52
- 53
- 54
- 55
- 56

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.